Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11863151 | 0.97 | SIGMAR1 (0.32) | MAOA | |
| SCHEMBL3450884 | 0.95 | HTR2A (0.30) | — | |
| SCHEMBL216358 | 0.89 | — | — | |
| SCHEMBL3581330 | 0.89 | MAOA (0.48) | MAOA | |
| SCHEMBL6294089 | 0.89 | MAOA (0.48) | MAOAMAOB | |
| SCHEMBL83982 | 0.89 | KCNH2 (0.42) | — | |
| SCHEMBL3098867 | 0.89 | TDP1 (0.33) | — | |
| SCHEMBL5735629 | 0.89 | MAOA (0.30) | MAOA | |
| SCHEMBL4630032 | 0.89 | — | — | |
| SCHEMBL14918942 | 0.89 | ALDH1A1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3374416-A1 | PHOTOALIGNMENT MATERIALS | ROLIC Technologies AG (CH) | 2018-09-19 | — | — | EP | disclosed |
| WO-2017081056-A1 | PHOTOALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-05-18 | — | — | WO | disclosed |
| EP-2748280-B1 | PHOTOREACTIVE COMPOUNDS | ROLIC AG (CH) | 2016-11-30 | — | — | EP | disclosed |
| US-20150291728-A1 | EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION | DAICEL CORPORATION (JP) | 2015-10-15 | — | — | US | disclosed |
| EP-2921513-A1 | EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION | Daicel Corporation (JP) | 2015-09-23 | — | — | EP | disclosed |
| CN-104755524-A | Epoxy compound, method for producing same, and curable epoxy resin composition | DAICEL CORP | 2015-07-01 | — | — | CN | disclosed |
| EP-2748280-A1 | PHOTOREACTIVE COMPOUNDS | Rolic AG (CH) | 2014-07-02 | — | — | EP | disclosed |
| WO-2013026691-A1 | PHOTOREACTIVE COMPOUNDS | ROLIC AG (CH) | 2013-02-28 | — | — | WO | disclosed |
| CN-101970749-B | Flame-retarder agent for polyester-based fiber, flame retardant polyester-based fiber using the same and method for producing the same | NICCA CHEMICAL CO | 2013-02-13 | — | — | CN | disclosed |
| US-8039534-B2 | Flame-retarder agent for polyester-based fiber, flame retardant polyester-based fiber using the same and method for producing the same | NICCA CHEMICAL CO., LTD. (JP) | 2011-10-18 | — | — | US | disclosed |
| CN-101970749-A | Flame-retarder agent for polyester-based fiber, flame retardant polyester-based fiber using the same and method for producing the same | NICCA CHEMICAL C | 2011-02-09 | — | — | CN | disclosed |
| US-20100311878-A1 | FLAME-RETARDER AGENT FOR POLYESTER-BASED FIBER, FLAME RETARDANT POLYESTER-BASED FIBER USING THE SAME AND METHOD FOR PRODUCING THE SAME | NICCA CHEMICAL CO., LTD. (JP) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291728-A1 | EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION | CBR1, SEM1, EEF1A1 | MAOA 2006/4885MAOB 1953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.